Cleaved N-terminal GSDMD Antibody (YA5850)
(Synonyms: Gsdmdc1, Gsdmd, Gasdermin-D, Gasdermin domain-containing protein 1)Based on 2 publication(s) in Google Scholar
Cleaved N-terminal GSDMD Antibody (YA5850) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Cleaved N-terminal GSDMD. GSDMD exists in multiple protein isoforms: the ~53 kDa GSDMD precursor, the ~35 kDa cleaved GSDMD-N fragment, and the ~22 kDa cleaved GSDMD-C fragment. This antibody specifically detects the ~35 kDa GSDMD-N fragment produced following GSDMD cleavage at Asp275.
-
Host:
Rabbit
-
Isotype:
IgG
-
Application:
WB, ICC/IF, ELISA
-
Reactivity :
Human, Mouse, Rat
-
Formulation:
Supplied in PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
-
Conjugation:
Non-conjugated
Publications Citing Use of MedChemExpress (MCE) Cleaved N-terminal GSDMD Antibody (YA5850)
More-
WB
-
WB
Applications
| Application |
WB
WB: Western Blot
|
ICC/IF
ICC/IF: Immunocytochemistry/
Immunofluorescence |
ELISA
ELISA: Enzyme Linked Immunosorbent Assay
|
|---|---|---|---|
| Dilution Ratio | 1:2000-1:10000 | 1:200-1:1000 | 1:5000-1:20000 |
Product Details
Cleaved N-terminal GSDMD Antibody (YA5850) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Cleaved N-terminal GSDMD. GSDMD exists in multiple protein isoforms: the ~53 kDa GSDMD precursor, the ~35 kDa cleaved GSDMD-N fragment, and the ~22 kDa cleaved GSDMD-C fragment. This antibody specifically detects the ~35 kDa GSDMD-N fragment produced following GSDMD cleavage at Asp275.
-
Host Rabbit
-
Clonality Monoclonal
-
Species ReactivityHuman, Mouse, Rat
-
Observed Molecular WeightObserved band size: 30-35 kDaNote: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
-
Calculated Molecular Weight Predicted band size: 35 kDa
Protein A
Non-conjugated
Unmodified
IgG
Product Properties
-
Appearance
Solution
-
Formulation
Supplied in PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
-
Concentration
Batch-dependent, Please check the COA for the concentration of each lot. Check Lot Concentration
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
Biomater Adv
Acoustic hydrogen delivery to treat PANoptosis induced by myocardial ischemia/reperfusion injury in rats. [Abstract]2026 Jun:183:214770. PMID: 41671925
Cleaved N-terminal GSDMD Antibody (YA5850) purchased from MedChemExpress. Usage Cited in: Biomater Adv. 2026 Jun:183:214770. [Abstract]
Western blot analysis was used to detect changes in GAPDH protein expression levels. Primary antibody:Cleaved N-terminal GSDMD Antibody (YA5850) (1:1000).
-
BMC Immunol
Diagnostic and prognostic value of deregulated miR-6822-3p in patients with severe pneumonia. [Abstract]2026 Jan 22;27(1):14. PMID: 41566413
Cleaved N-terminal GSDMD Antibody (YA5850) purchased from MedChemExpress. Usage Cited in: BMC Immunol. 2026 Jan 22;27(1):14. [Abstract]
Western blot (WB) analysis of pyroptosis-related proteins in THP-1 cells. The primary antibodies used in the experiment were NLRP3, cleaved caspase-1 (Cleaved-Caspase-1 Antibody, HY-P80622), cleaved N-terminal GSDMD (Cleaved N-terminal GSDMD Antibody (YA5850), HY-P86158), and β-actin.
Background
-
Function
Cleaved N-terminal GSDMD is a Precursor of a pore-forming protein that plays a key role in host defense against pathogen infection and danger signals. This form constitutes the precursor of the pore-forming protein: upon cleavage, the released N-terminal moiety (Gasdermin-D, N-terminal) binds to membranes and forms pores, triggering pyroptosis; Promotes pyroptosis in response to microbial infection and danger signals. Produced by the cleavage of gasdermin-D by inflammatory caspases CASP1, CASP4 or CASP5 in response to canonical, as well as non-canonical (such as cytosolic LPS) inflammasome activators. After cleavage, moves to the plasma membrane where it strongly binds to inner leaflet lipids, including monophosphorylated phosphatidylinositols, such as phosphatidylinositol 4-phosphate, bisphosphorylated phosphatidylinositols, such as phosphatidylinositol (4,5)-bisphosphate, as well as phosphatidylinositol (3,4,5)-bisphosphate, and more weakly to phosphatidic acid and phosphatidylserine. Homooligomerizes within the membrane and forms pores of 10-15 nanometers (nm) of inner diameter, allowing the release of mature interleukin-1 (IL1B and IL18) and triggering pyroptosis. Gasdermin pores also allow the release of mature caspase-7 (CASP7). In some, but not all, cells types, pyroptosis is followed by pyroptotic cell death, which is caused by downstream activation of ninjurin-1 (NINJ1), which mediates membrane rupture (cytolysis). Also forms pores in the mitochondrial membrane, resulting in release of mitochondrial DNA (mtDNA) into the cytosol. Gasdermin-D, N-terminal released from pyroptotic cells into the extracellular milieu rapidly binds to and kills both Gram-negative and Gram-positive bacteria, without harming neighboring mammalian cells, as it does not disrupt the plasma membrane from the outside due to lipid-binding specificity. Under cell culture conditions, also active against intracellular bacteria, such as Listeria monocytogenes. Also active in response to MAP3K7/TAK1 inactivation by Yersinia toxin YopJ, which triggers cleavage by CASP8 and subsequent activation. Required for mucosal tissue defense against enteric pathogens. Activation of the non-canonical inflammasome in brain endothelial cells can lead to excessive pyroptosis, leading to blood-brain barrier breakdown. Strongly binds to bacterial and mitochondrial lipids, including cardiolipin. Does not bind to unphosphorylated phosphatidylinositol, phosphatidylethanolamine nor phosphatidylcholine; Transcription coactivator produced by the cleavage by CASP3 or CASP7 in the upper small intestine in response to dietary antigens. Required to maintain food tolerance in small intestine: translocates to the nucleus and acts as a coactivator for STAT1 to induce the transcription of CIITA and MHC class II molecules, which in turn induce type 1 regulatory T (Tr1) cells in upper small intestine; Produced by the cleavage by papain allergen. After cleavage, moves to the plasma membrane and homooligomerizes within the membrane and forms pores of 10-15 nanometers (nm) of inner diameter, allowing the specific release of mature interleukin-33 (IL33), promoting type 2 inflammatory immune response[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16].
-
Subcellular Localization
Cytoplasm, cytosol; Inflammasome; Cell membrane; Multi-pass membrane protein; Secreted; Mitochondrion membrane; Cytoplasm, cytosol; Nucleus; Cytoplasm, cytosol
-
Expression
Tissue_specificity:This gene is expressed in the upper basal layer cells of the esophagus, as well as in the gastric isthmus/neck, gastric pits, and gastric glands, suggesting that it is preferentially expressed in differentiated cells. -
Subunit
Homooligomer; homooligomeric ring-shaped pore complex containing 27-28 subunits when inserted in the membrane (PubMed:33883744, PubMed:34289345, PubMed:38040708).
-
SwissProt ID
-
Synonyms
Gsdmdc1, Gsdmd, Gasdermin-D, Gasdermin domain-containing protein 1
Documentation
-
Data Sheet (264 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
User Guide for Antibodies (1077 KB)
References
[1]. Shi J, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015 Oct 29;526(7575):660-5. [Content Brief]
[2]. Kayagaki N, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature. 2015 Oct 29;526(7575):666-71. [Content Brief]
[3]. Ding J, et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature. 2016 Jul 7;535(7610):111-6. [Content Brief]
[4]. Sborgi L, et al. GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death. EMBO J. 2016 Aug 15;35(16):1766-78. [Content Brief]
[5]. Taabazuing CY, et al. Pyroptosis and Apoptosis Pathways Engage in Bidirectional Crosstalk in Monocytes and Macrophages. Cell Chem Biol. 2017 Apr 20;24(4):507-514.e4. [Content Brief]
[6]. Humphries F, et al. Succination inactivates gasdermin D and blocks pyroptosis. Science. 2020 Sep 25;369(6511):1633-1637. [Content Brief]
[7]. Evavold CL, et al. Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathway. Cell. 2021 Aug 19;184(17):4495-4511.e19. [Content Brief]
[8]. Kopp A, et al. Pyroptosis inhibiting nanobodies block Gasdermin D pore formation. Nat Commun. 2023 Dec 1;14(1):7923. [Content Brief]
[9]. Balasubramanian A, et al. The palmitoylation of gasdermin D directs its membrane translocation and pore formation during pyroptosis. Sci Immunol. 2024 Apr 12;9(94):eadn1452. [Content Brief]
[10]. Du G, et al. ROS-dependent S-palmitoylation activates cleaved and intact gasdermin D. Nature. 2024 Jun;630(8016):437-446. [Content Brief]
[11]. Mulvihill E, et al. Mechanism of membrane pore formation by human gasdermin-D. EMBO J. 2018 Jul 13;37(14):. [Content Brief]
[12]. Chai Q, et al. A bacterial phospholipid phosphatase inhibits host pyroptosis by hijacking ubiquitin. Science. 2022 Oct 14;378(6616):eabq0132. [Content Brief]
[13]. Xia S, et al. Gasdermin D pore structure reveals preferential release of mature interleukin-1. Nature. 2021 May;593(7860):607-611. [Content Brief]
[14]. Kayagaki N, et al. NINJ1 mediates plasma membrane rupture during lytic cell death. Nature. 2021 Mar;591(7848):131-136. [Content Brief]
[15]. Degen M, et al. Structural basis of NINJ1-mediated plasma membrane rupture in cell death. Nature. 2023 Jun;618(7967):1065-1071. [Content Brief]
[16]. Chen W, et al. Allergen protease-activated stress granule assembly and gasdermin D fragmentation control interleukin-33 secretion. Nat Immunol. 2022 Jul;23(7):1021-1030. [Content Brief]